Cumberland Pharmaceuticals (CPIX) Misses Q4 EPS by 13c

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of ($0.13), $0.13 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $8.3 million versus the consensus estimate of $9.19 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Danone SA (BN:FP) (DANOY) PT Raised to EUR63 at Deutsche Bank
• Berenberg Starts Brooks Macdonald Group PLC (BRK:LN) at Buy